Invention Grant
US08546433B2 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
有权
用于联合治疗用于预防，治疗或治疗转移性癌症的Axl抑制剂
- Patent Title: Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
- Patent Title (中): 用于联合治疗用于预防，治疗或治疗转移性癌症的Axl抑制剂
-
Application No.: US12688746Application Date: 2010-01-15
-
Publication No.: US08546433B2Publication Date: 2013-10-01
- Inventor: Yasumichi Hitoshi , Sacha Holland , Donald G. Payan
- Applicant: Yasumichi Hitoshi , Sacha Holland , Donald G. Payan
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Seed IP Law Group PLLC
- Agent Travis Young
- Main IPC: A01N43/64
- IPC: A01N43/64 ; A61K31/41 ; C07D413/00
Abstract:
This invention is directed to methods of preventing, treating or managing cancer, preferably metastatic cancer, in a patient. The methods comprise administering an effective amount of an Axl inhibitor in combination with the administration of an effective amount of one or more chemotherapeutic agents.
Public/Granted literature
- US20100196511A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER Public/Granted day:2010-08-05
Information query
IPC分类:
